TTR and amyloidosis: The differential interaction and processing of an aggregation-prone, disease-associated transthyretin variant with human cardiac cells, compared with a non-disease associated transthyretin mutant may explain the basis of the early events of tissue damage in the transthyretin amyloidoses.